The Potential of Five Immune-Related Prognostic Genes to Predict Survival and Response to Immune Checkpoint Inhibitors for Soft Tissue Sarcomas Based on Multi-Omic Study.

Gu, Hui-Yun; Lin, Lu-Lu; Zhang, Chao; Yang, Min; Zhong, Hou-Cheng; Wei, Ren-Xiong

Gu, Hui-Yun; Lin, Lu-Lu; Zhang, Chao; Yang, Min; Zhong, Hou-Cheng; Wei, Ren-Xiong.

Afiliação

Gu HY; Department of Spine and Orthopedic Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Lin LL; Department of Pathology and Pathophysiology, School of Basic Medicine, Wuhan University, Wuhan, China.
Zhang C; Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Yang M; Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Zhong HC; Department of Spine and Orthopedic Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wei RX; Department of Spine and Orthopedic Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Front Oncol ; 10: 1317, 2020.

Article em En | MEDLINE | ID: mdl-32850416

Palavras-chave

DNA methylation; immune-related prognostic genes (model); multi-omic study; somatic variants; tumor immune microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google